MedPath

Transcutaneous Electrical Stimulation in Obstructive Sleep Apnea

Not Applicable
Completed
Conditions
Obstructive Sleep Apnea
Interventions
Device: Transcutaneous electrical stimulation
Registration Number
NCT04932486
Lead Sponsor
Sunrise
Brief Summary

The aim of this study is to assess the efficacy of transcutaneous electrical stimulation of the upper airway muscles in patients with obstructive sleep apnea.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
42
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Transcutaneous electrical stimulationTranscutaneous electrical stimulationParticipants will be asked to use the stimulator for 6 weeks at home. The study objectives will be evaluated after 6 weeks post-activation of the device.
Primary Outcome Measures
NameTimeMethod
Apnea-hypopnea index (AHI)6 weeks

Change from baseline to 6 weeks in the apnea-hypopnea index (AHI)

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Respisom

🇧🇪

Namur, Belgium

© Copyright 2025. All Rights Reserved by MedPath